LinkedIn Profile

Access Proteocyte Diagnostics historical Linkedin company profile data on number of followers, employee headcount and more

Rows

Open dataset
Ticker Symbol Entity Name As Of Date Company Name Followers Employees on Linkedin Link Industry Date Added Date Updated Description Website Specialities Logo HQ.Street HQ.City HQ.State HQ.Country HQ.Postal Headcount change in past 24 months Company Name Sector Industry
private:proteocytediagnostics 2329812 May 31st, 2019 12:00AM Proteocyte AI 156 3.00 Open Medical Devices May 31st, 2019 03:47AM May 31st, 2019 03:47AM Designing tests that accurately predict your risk of developing cancer. Proteocyte AI is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until August 1, 2018. Open Oral Dysplasia, Oral Cancer, Cancer Biomarkers, Image Analysis Open 101 College St. Suite 200 Toronto ON CA M5G1L7 Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 17th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 17th, 2018 02:25PM Feb 17th, 2018 02:25PM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 16th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 16th, 2017 08:15AM Feb 16th, 2017 08:15AM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 15th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 15th, 2017 10:07AM Feb 15th, 2017 10:07AM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 14th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 14th, 2017 01:50PM Feb 14th, 2017 01:50PM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 13th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 13th, 2017 04:11PM Feb 13th, 2017 04:11PM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 12th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 12th, 2017 04:15AM Feb 12th, 2017 04:15AM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 11th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 11th, 2017 05:35AM Feb 11th, 2017 05:35AM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 10th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 10th, 2017 06:43AM Feb 10th, 2017 06:43AM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services
private:proteocytediagnostics 2329812 Feb 9th, 2018 12:00AM Proteocyte Diagnostics Inc. 58 5.00 Open Medical Devices Feb 9th, 2017 08:57AM Feb 9th, 2017 08:57AM Designing tests that accurately predict your risk of developing cancer. Proteocyte Diagnostics is developing a platform of solutions to accurately predict your risk of developing cancer. Our platform identifies specific protein biomarkers that operate in combination with proprietary algorithms, advanced imaging and digital pathology enabling us to accurately predict an individuals’ probability of non-cancerous lesions progressing to invasive cancer. Our vision is to reduce the incidence of cancer around the world and we will do that by living our mission; saving patients’ lives by predicting progression to cancer. We will provide innovative insight that will allow healthcare professionals to treat earlier knowing that early diagnosis leads to improved outcomes and extends the lives of patients around the world. Our first product is Straticyte, the first digitally delivered oral cancer predictor. Straticyte is complimentary until September 29, 2017. Proteocyte Diagnostics Health Care Health Care Equipment & Services

Request a demo to view additional historical data, and much more.

Request Demo

Make fast
queries

No longer rely on engineers to access data; build and share queries with intuitive tools, and derive insights in real time.

Bookmark queries with your team

Save and share custom queries using a private bookmarking feature, accessible to your whole team.

Be first to know with alerts

Scan data points across millions of companies and receive emails when relevant metrics cross critical thresholds.

Visualize data for quick insights

Create custom keyword-based word clouds, charts, and advanced visualizations to quickly analyze the data.

Map competitor locations

Analyze competitor presence and growth over time by overlaying store locations with the Nearby Competitor feature.

Add widgets to your dashboards

Access existing maps, charts, word clouds, and other visualizations to understand your data quickly. Or build custom widgets to view data just the way you want it.